Robert Lenz
Vermögen: 509 614 $ am 31.07.2026
Vermögen: 509 614 $ am 31.07.2026
Robert A. Lenz is currently Co-Managing Director at Lenz, Kämper GmbH & Co. KG.
He is also an Independent Director at LB Pharmaceuticals, Inc. starting in 2026 and an Independent Director at NovaBridge Biosciences starting in 2025.
Formerly, Dr. Lenz was Senior Vice President & Head-Global Development at Amgen, Inc. and Head-Research & Development at Neumora Therapeutics, Inc. Dr. Lenz earned a doctorate from the University of Maryland and completed undergraduate studies at Dickinson College.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 18.02.2025 | 309’092 ( 0.17% ) | 497 638 $ | 31.07.2026 | |
| 22.08.2026 | 17’218 ( 0.01% ) | 11 975 $ | 31.07.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| NOVABRIDGE BIOSCIENCES | Direktor/Vorstandsmitglied | 22.08.2025 |
| LB PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 06.03.2026 |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Vorstandsvorsitzender | - |
| Unternehmen | Position | Ende |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Dickinson College
Dickinson College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Maryland
University of Maryland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lenz, Kämper GmbH & Co. KG
Lenz, Kämper GmbH & Co. KG Electrical ProductsProducer Manufacturing Manufactures and supplies bent wire parts | Producer Manufacturing |
LB Pharmaceuticals, Inc.
LB Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company developing novel therapies for the treatment of schizophrenia, bipolar depression and neuropsychiatric diseases | Health Technology |
I-Mab
I-Mab Pharmaceuticals: MajorHealth Technology Develops and manufactures medicines for cancer and autoimmune diseases | Health Technology |
Neumora Therapeutics, Inc.
Neumora Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops medicines for brain diseases | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen